GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Short-Term Capital Lease Obligation

Genexine (XKRX:095700) Short-Term Capital Lease Obligation : ₩89 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine Short-Term Capital Lease Obligation?

Genexine's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩89 Mil.

Genexine's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩114 Mil) to Dec. 2023 (₩118 Mil) but then declined from Dec. 2023 (₩118 Mil) to Mar. 2024 (₩89 Mil).

Genexine's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩230 Mil) to Dec. 2022 (₩186 Mil) and declined from Dec. 2022 (₩186 Mil) to Dec. 2023 (₩118 Mil).

Genexine Short-Term Capital Lease Obligation Historical Data

The historical data trend for Genexine's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Short-Term Capital Lease Obligation Chart

Genexine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.29 169.66 229.67 186.46 118.12

Genexine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.01 144.79 113.55 118.12 88.85

Genexine Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Genexine Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Genexine's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Genexine (XKRX:095700) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:228760 XKRX:216080 XKRX:323990 XKRX:334970 XKRX:005690 XKRX:358570 XKRX:199800 XKRX:115450 XKRX:060590 XKRX:011000 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Website
http://www.genexine.com
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines